Daily News Podcast

MDedge Daily News: Which diabetes drug boosts survival best?

Publish date: April 18, 2018

 

Which diabetes drug boosts survival best? Community cancer clinics keep closing. A champion arises among oral anticoagulants. And there’s new promise in early-stage lung cancer.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Does incretin therapy increase pancreatic cancer risk?
MDedge Hematology and Oncology
Empagliflozin’s heart failure benefits linked to volume drop
MDedge Hematology and Oncology
New hematologic, cardiovascular system link may have therapeutic implications
MDedge Hematology and Oncology
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Hematology and Oncology
MDedge Daily News: Have ‘The Talk’ about medical marijuana
MDedge Hematology and Oncology
MDedge Daily News: Treating H. pylori slashed new gastric cancers
MDedge Hematology and Oncology
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Hematology and Oncology
MDedge Daily News: How European data privacy rules may cost you
MDedge Hematology and Oncology
Diabetes from checkpoint inhibitors probably means lifelong insulin
MDedge Hematology and Oncology
MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Hematology and Oncology